Skip to main content
Find a DoctorGet Care Now
Skip to main content
Search icon magnifying glass

Contrast

Contact

Share

Give Now

MyChart

Help

Karen DuBois-Walton, PhD and Jocelyn Cunningham named to Yale New Haven Hospital’s Board of Trustees

Thursday, October 3, 2019

Karen DuBois-Walton, PhD YNHH Board of Trustees Jocelyn Cunningham, YNHH Board of Trustees
(Karen DuBois-Walton, PhD and Jocelyn Cunningham)
New Haven, CT (October 3, 2019) – Yale New Haven Hospital (YNHH) has named Karen Dubois-Walton, PhD and Jocelyn Cunningham as incoming members to the YNHH Board of trustees. Ms. Dubois-Walton will join the Board on October 1 while Ms. Cunningham officially joins on December 1.

“We are so excited to have Karen and Jocelyn join our Board of Trustees – they bring us a wealth of experience and knowledge,” said Marna P. Borgstrom, CEO, Yale New Haven Hospital and Yale New Haven Health. “Their unique perspectives will provide new insight and vision to help grow Yale New Haven Hospital.”

Ms. DuBois-Walton currently serves as the president of the Elm City Communities/Housing Authority, president of The Glendower Group, LLC and president of 360 Management Group, Co. responsible for administrative, programmatic and policy direction. As executive director of the Housing Authority, she works with some of the city’s poorest families, providing them basic housing and a host of skills-building and other supportive services. Ms. DuBois-Walton has been involved in the New Haven for many years, having served as the COO for the Housing Authority of New Haven, as well as chief of staff for Mayor John DeStefano, Jr. A trained clinical psychologist, she also served in positions with the State of Connecticut Department of Mental Health and Addiction Services and Yale Child Study Center.

Ms. Cunningham is a senior partner in Deloitte’s Financial Services Industry (FSI) practice in New York. She has held numerous leadership positions within the FSI practice and the Consulting practice. She has also held senior client leadership roles. Ms. Cunningham serves Deloitte’s largest banking and capital market clients and has significant experience in both securities and banking. Ms. Cunningham is committed to Diversity and Inclusion and leads certain of the Firm’s activities including representing Deloitte on the US 30% Club Steering Committee and supporting the Deloitte Corporate Governance efforts on diversity. She is a member of the Senior Partner Advisory Committee of the Firm.

“Community perspectives are essential to the ongoing success of Yale New Haven Hospital, and we are so appreciative that both Jocelyn and Karen are donating their time and experience to Yale New Haven Hospital,” said Mary C. Farrell, YNHH chair of the Board of Trustees. “We are delighted to have them on our team.”

Similar Articles

7/21/2026

Yale New Haven Hospital introduces innovative implantable technology to advance stroke rehabilitation

NEW HAVEN, CT. — [July 21, 2026] — Every 40 seconds, someone in the United States has a stroke. Yale New Haven Hospital is bringing new hope to stroke survivors with the introduction of an innovative, FDA-approved device that enhances rehabilitation by combining traditional therapy with targeted nerve stimulation.

7/21/2026

Yale New Haven Children’s Hospital Unveils New Children’s Crisis Intervention Center

New Haven, Conn. (July 21, 2026) — Yale New Haven Children’s Hospital today unveiled its new Children’s Crisis Intervention Center, a dedicated behavioral health treatment space within the Children’s Emergency Department that will begin caring for patients in August. Designed for children up to age 15 experiencing a behavioral health crisis, the Center provides a calm, therapeutic environment where young patients can receive rapid evaluation, stabilization and connection to ongoing services.

7/10/2026

Yale New Haven Health Heart and Vascular Center honored with 2025 Larry Kraiss Quality Award for excellence in vascular care

New Haven, CT (July 10, 2026)_ Yale New Haven Health Heart and Vascular Center is proud to announce that it has been named a recipient of the 2025 Larry Kraiss Quality Award, a prestigious recognition presented by the Society for Vascular Surgery Patient Safety Organization (SVS-PSO) to hospitals and vascular programs that demonstrate exceptional commitment to improving patient outcomes through collaboration, research, and quality improvement.